Belotti D - Search Results

1

Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator.

Kaur G, Belotti D, Burger AM, Fisher-Nielson K, Borsotti P, Riccardi E, Thillainathan J, Hollingshead M, Sausville EA, Giavazzi R. Kaur G, et al. Among authors: belotti d. Clin Cancer Res. 2024 May 1;30(9):1996. doi: 10.1158/1078-0432.CCR-24-0857. Clin Cancer Res. 2024. PMID: 38690595 No abstract available.

2

Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.

Kaur G, Belotti D, Burger AM, Fisher-Nielson K, Borsotti P, Riccardi E, Thillainathan J, Hollingshead M, Sausville EA, Giavazzi R. Kaur G, et al. Among authors: belotti d. Clin Cancer Res. 2004 Jul 15;10(14):4813-21. doi: 10.1158/1078-0432.CCR-03-0795. Clin Cancer Res. 2004. PMID: 15269157

3

The microtubule-affecting drug paclitaxel has antiangiogenic activity.

Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G. Belotti D, et al. Clin Cancer Res. 1996 Nov;2(11):1843-9. Clin Cancer Res. 1996. PMID: 9816139

4

The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.

Taraboletti G, Belotti D, Borsotti P, Vergani V, Rusnati M, Presta M, Giavazzi R. Taraboletti G, et al. Among authors: belotti d. Cell Growth Differ. 1997 Apr;8(4):471-9. Cell Growth Differ. 1997. PMID: 9101093

5

Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion.

Belotti D, Calcagno C, Garofalo A, Caronia D, Riccardi E, Giavazzi R, Taraboletti G. Belotti D, et al. Mol Cancer Res. 2008 Apr;6(4):525-34. doi: 10.1158/1541-7786.MCR-07-0366. Mol Cancer Res. 2008. PMID: 18403633 Free article.

6

Endothelial cell migration and invasiveness are induced by a soluble factor produced by murine endothelioma cells transformed by polyoma virus middle T oncogene.

Taraboletti G, Belotti D, Dejana E, Mantovani A, Giavazzi R. Taraboletti G, et al. Among authors: belotti d. Cancer Res. 1993 Aug 15;53(16):3812-6. Cancer Res. 1993. PMID: 8393382

7

Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells.

Belotti D, Rieppi M, Nicoletti MI, Casazza AM, Fojo T, Taraboletti G, Giavazzi R. Belotti D, et al. Clin Cancer Res. 1996 Oct;2(10):1725-30. Clin Cancer Res. 1996. PMID: 9816123

8

Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.

Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G, Giavazzi R. Belotti D, et al. Cancer Res. 2003 Sep 1;63(17):5224-9. Cancer Res. 2003. PMID: 14500349

9

Antiangiogenic activity of trabectedin in myxoid liposarcoma: involvement of host TIMP-1 and TIMP-2 and tumor thrombospondin-1.

Dossi R, Frapolli R, Di Giandomenico S, Paracchini L, Bozzi F, Brich S, Castiglioni V, Borsotti P, Belotti D, Uboldi S, Sanfilippo R, Erba E, Giavazzi R, Marchini S, Pilotti S, D'Incalci M, Taraboletti G. Dossi R, et al. Among authors: d incalci m, belotti d. Int J Cancer. 2015 Feb 1;136(3):721-9. doi: 10.1002/ijc.29023. Epub 2014 Jun 19. Int J Cancer. 2015. PMID: 24917554

10

Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.

Carminati L, Pinessi D, Borsotti P, Minoli L, Giavazzi R, D'Incalci M, Belotti D, Taraboletti G. Carminati L, et al. Among authors: d incalci m, belotti d. Carcinogenesis. 2019 Apr 29;40(2):303-312. doi: 10.1093/carcin/bgy177. Carcinogenesis. 2019. PMID: 30544170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters